ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.9 | SP4 |
PML
|
ENSG00000140464.15 | PML |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP4 | hg19_v2_chr7_+_21467642_21467671 | -0.50 | 4.8e-02 | Click! |
PML | hg19_v2_chr15_+_74287118_74287144 | -0.43 | 9.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_235860616 | 12.40 |
ENST00000392011.2 |
SH3BP4 |
SH3-domain binding protein 4 |
chr12_-_106641728 | 10.59 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr3_-_149688502 | 8.86 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr3_-_149688655 | 8.57 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr14_-_53417732 | 8.55 |
ENST00000399304.3 ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2 |
fermitin family member 2 |
chr1_-_20812690 | 8.26 |
ENST00000375078.3 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr4_-_177713788 | 8.07 |
ENST00000280193.2 |
VEGFC |
vascular endothelial growth factor C |
chr11_-_12030629 | 7.80 |
ENST00000396505.2 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr2_-_161264385 | 7.78 |
ENST00000409972.1 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr10_-_15413035 | 7.77 |
ENST00000378116.4 ENST00000455654.1 |
FAM171A1 |
family with sequence similarity 171, member A1 |
chr10_-_126849068 | 7.66 |
ENST00000494626.2 ENST00000337195.5 |
CTBP2 |
C-terminal binding protein 2 |
chr6_+_17393839 | 7.33 |
ENST00000489374.1 ENST00000378990.2 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr1_-_85930823 | 7.31 |
ENST00000284031.8 ENST00000539042.1 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
chr2_+_9346892 | 7.31 |
ENST00000281419.3 ENST00000315273.4 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr12_-_124457257 | 7.20 |
ENST00000545891.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr8_+_136469684 | 7.00 |
ENST00000355849.5 |
KHDRBS3 |
KH domain containing, RNA binding, signal transduction associated 3 |
chr2_-_224903995 | 6.90 |
ENST00000409304.1 ENST00000454956.1 ENST00000258405.4 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr3_-_185542817 | 6.66 |
ENST00000382199.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr6_+_17393888 | 6.66 |
ENST00000493172.1 ENST00000465994.1 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr1_+_182992545 | 6.39 |
ENST00000258341.4 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
chr3_-_185542761 | 6.39 |
ENST00000457616.2 ENST00000346192.3 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr21_+_42539701 | 6.37 |
ENST00000330333.6 ENST00000328735.6 ENST00000347667.5 |
BACE2 |
beta-site APP-cleaving enzyme 2 |
chr17_-_882966 | 6.35 |
ENST00000336868.3 |
NXN |
nucleoredoxin |
chr1_-_225840747 | 6.31 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr6_-_3752222 | 6.17 |
ENST00000380283.4 |
PXDC1 |
PX domain containing 1 |
chr11_-_12030905 | 6.04 |
ENST00000326932.4 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr10_-_126849588 | 6.00 |
ENST00000411419.2 |
CTBP2 |
C-terminal binding protein 2 |
chr3_-_149688896 | 5.95 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chr10_+_124221036 | 5.93 |
ENST00000368984.3 |
HTRA1 |
HtrA serine peptidase 1 |
chr2_-_1748214 | 5.84 |
ENST00000433670.1 ENST00000425171.1 ENST00000252804.4 |
PXDN |
peroxidasin homolog (Drosophila) |
chrX_+_135229600 | 5.82 |
ENST00000370690.3 |
FHL1 |
four and a half LIM domains 1 |
chr20_-_23618582 | 5.80 |
ENST00000398411.1 ENST00000376925.3 |
CST3 |
cystatin C |
chr1_+_43996518 | 5.72 |
ENST00000359947.4 ENST00000438120.1 |
PTPRF |
protein tyrosine phosphatase, receptor type, F |
chr17_-_74707037 | 5.63 |
ENST00000355797.3 ENST00000375036.2 ENST00000449428.2 |
MXRA7 |
matrix-remodelling associated 7 |
chr7_-_131241361 | 5.43 |
ENST00000378555.3 ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL |
podocalyxin-like |
chr21_+_46825032 | 5.43 |
ENST00000400337.2 |
COL18A1 |
collagen, type XVIII, alpha 1 |
chr13_-_77460525 | 5.39 |
ENST00000377474.2 ENST00000317765.2 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
chr2_-_175869936 | 5.36 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr15_-_90358048 | 5.30 |
ENST00000300060.6 ENST00000560137.1 |
ANPEP |
alanyl (membrane) aminopeptidase |
chr6_-_132272504 | 5.25 |
ENST00000367976.3 |
CTGF |
connective tissue growth factor |
chr14_-_30396802 | 5.22 |
ENST00000415220.2 |
PRKD1 |
protein kinase D1 |
chr20_-_50385138 | 5.20 |
ENST00000338821.5 |
ATP9A |
ATPase, class II, type 9A |
chr12_-_124457371 | 5.15 |
ENST00000238156.3 ENST00000545037.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr2_+_241375069 | 5.13 |
ENST00000264039.2 |
GPC1 |
glypican 1 |
chr2_-_161349909 | 5.13 |
ENST00000392753.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr13_-_110438914 | 5.01 |
ENST00000375856.3 |
IRS2 |
insulin receptor substrate 2 |
chr1_-_94703118 | 4.96 |
ENST00000260526.6 ENST00000370217.3 |
ARHGAP29 |
Rho GTPase activating protein 29 |
chrX_+_135229731 | 4.91 |
ENST00000420362.1 |
FHL1 |
four and a half LIM domains 1 |
chr11_+_19798964 | 4.89 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
chr3_-_32022733 | 4.85 |
ENST00000438237.2 ENST00000396556.2 |
OSBPL10 |
oxysterol binding protein-like 10 |
chr12_+_6309517 | 4.84 |
ENST00000382519.4 ENST00000009180.4 |
CD9 |
CD9 molecule |
chr7_+_79764104 | 4.83 |
ENST00000351004.3 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr3_-_129325660 | 4.82 |
ENST00000324093.4 ENST00000393239.1 |
PLXND1 |
plexin D1 |
chr13_+_98795434 | 4.78 |
ENST00000376586.2 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chrX_+_9754461 | 4.75 |
ENST00000380913.3 |
SHROOM2 |
shroom family member 2 |
chr17_-_78009647 | 4.75 |
ENST00000310924.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr1_-_95392635 | 4.71 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr20_-_50384864 | 4.61 |
ENST00000311637.5 ENST00000402822.1 |
ATP9A |
ATPase, class II, type 9A |
chrX_+_135229559 | 4.60 |
ENST00000394155.2 |
FHL1 |
four and a half LIM domains 1 |
chr16_-_4166186 | 4.58 |
ENST00000294016.3 |
ADCY9 |
adenylate cyclase 9 |
chr2_-_110371412 | 4.54 |
ENST00000415095.1 ENST00000334001.6 ENST00000437928.1 ENST00000493445.1 ENST00000397714.2 ENST00000461295.1 |
SEPT10 |
septin 10 |
chr11_-_2160611 | 4.54 |
ENST00000416167.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr2_-_110371720 | 4.53 |
ENST00000356688.4 |
SEPT10 |
septin 10 |
chr12_+_6308881 | 4.53 |
ENST00000382518.1 ENST00000536586.1 |
CD9 |
CD9 molecule |
chr9_+_504674 | 4.52 |
ENST00000382297.2 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr17_-_76921459 | 4.48 |
ENST00000262768.7 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr22_+_38142235 | 4.47 |
ENST00000407319.2 ENST00000403663.2 ENST00000428075.1 |
TRIOBP |
TRIO and F-actin binding protein |
chr6_-_138428613 | 4.41 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr1_+_169075554 | 4.40 |
ENST00000367815.4 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr2_-_175870085 | 4.38 |
ENST00000409156.3 |
CHN1 |
chimerin 1 |
chr8_+_94929077 | 4.38 |
ENST00000297598.4 ENST00000520614.1 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr8_+_22436635 | 4.38 |
ENST00000452226.1 ENST00000397760.4 ENST00000339162.7 ENST00000397761.2 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr14_+_105941118 | 4.26 |
ENST00000550577.1 ENST00000538259.2 |
CRIP2 |
cysteine-rich protein 2 |
chr10_-_17659357 | 4.26 |
ENST00000326961.6 ENST00000361271.3 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr14_-_75079026 | 4.26 |
ENST00000261978.4 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
chr2_-_161350305 | 4.25 |
ENST00000348849.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr11_+_86511569 | 4.24 |
ENST00000441050.1 |
PRSS23 |
protease, serine, 23 |
chr5_+_17217669 | 4.24 |
ENST00000322611.3 |
BASP1 |
brain abundant, membrane attached signal protein 1 |
chr19_-_1568057 | 4.21 |
ENST00000402693.4 ENST00000388824.6 |
MEX3D |
mex-3 RNA binding family member D |
chr9_-_88714421 | 4.17 |
ENST00000388712.3 |
GOLM1 |
golgi membrane protein 1 |
chr13_+_98795505 | 4.14 |
ENST00000319562.6 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr4_-_57976544 | 4.11 |
ENST00000295666.4 ENST00000537922.1 |
IGFBP7 |
insulin-like growth factor binding protein 7 |
chr8_-_11725549 | 4.05 |
ENST00000505496.2 ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB |
cathepsin B |
chr14_-_65438865 | 4.02 |
ENST00000267512.5 |
RAB15 |
RAB15, member RAS oncogene family |
chr8_+_94929110 | 4.01 |
ENST00000520728.1 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr2_-_110371777 | 3.91 |
ENST00000397712.2 |
SEPT10 |
septin 10 |
chr4_-_22517620 | 3.90 |
ENST00000502482.1 ENST00000334304.5 |
GPR125 |
G protein-coupled receptor 125 |
chr7_-_558876 | 3.89 |
ENST00000354513.5 ENST00000402802.3 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
chr10_-_17659234 | 3.87 |
ENST00000466335.1 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr10_-_735553 | 3.86 |
ENST00000280886.6 ENST00000423550.1 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr8_+_1772132 | 3.83 |
ENST00000349830.3 ENST00000520359.1 ENST00000518288.1 ENST00000398560.1 |
ARHGEF10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
chr14_-_52535712 | 3.82 |
ENST00000216286.5 ENST00000541773.1 |
NID2 |
nidogen 2 (osteonidogen) |
chr8_+_94929168 | 3.81 |
ENST00000518107.1 ENST00000396200.3 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr2_+_85360499 | 3.81 |
ENST00000282111.3 |
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
chr10_-_125851961 | 3.80 |
ENST00000346248.5 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr13_-_114567034 | 3.77 |
ENST00000327773.6 ENST00000357389.3 |
GAS6 |
growth arrest-specific 6 |
chr15_+_39873268 | 3.77 |
ENST00000397591.2 ENST00000260356.5 |
THBS1 |
thrombospondin 1 |
chr7_+_116166331 | 3.72 |
ENST00000393468.1 ENST00000393467.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr2_+_36582857 | 3.71 |
ENST00000280527.2 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
chr12_-_13153139 | 3.71 |
ENST00000536942.1 ENST00000014930.4 |
HEBP1 |
heme binding protein 1 |
chr10_+_128593978 | 3.69 |
ENST00000280333.6 |
DOCK1 |
dedicator of cytokinesis 1 |
chrX_+_2609356 | 3.69 |
ENST00000381180.3 ENST00000449611.1 |
CD99 |
CD99 molecule |
chr19_-_18717627 | 3.69 |
ENST00000392386.3 |
CRLF1 |
cytokine receptor-like factor 1 |
chr12_-_47473707 | 3.68 |
ENST00000429635.1 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr17_-_62658186 | 3.63 |
ENST00000262435.9 |
SMURF2 |
SMAD specific E3 ubiquitin protein ligase 2 |
chr1_-_22263790 | 3.61 |
ENST00000374695.3 |
HSPG2 |
heparan sulfate proteoglycan 2 |
chr3_-_120170052 | 3.59 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr7_-_47621736 | 3.58 |
ENST00000311160.9 |
TNS3 |
tensin 3 |
chr12_-_47473642 | 3.57 |
ENST00000266581.4 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr19_-_19051927 | 3.57 |
ENST00000600077.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr5_-_16936340 | 3.56 |
ENST00000507288.1 ENST00000513610.1 |
MYO10 |
myosin X |
chrX_+_2609317 | 3.49 |
ENST00000381187.3 ENST00000381184.1 |
CD99 |
CD99 molecule |
chr17_-_46115122 | 3.47 |
ENST00000006101.4 |
COPZ2 |
coatomer protein complex, subunit zeta 2 |
chrX_+_2609207 | 3.47 |
ENST00000381192.3 |
CD99 |
CD99 molecule |
chr9_+_133320339 | 3.46 |
ENST00000372394.1 ENST00000372393.3 ENST00000422569.1 |
ASS1 |
argininosuccinate synthase 1 |
chr9_-_13279563 | 3.46 |
ENST00000541718.1 |
MPDZ |
multiple PDZ domain protein |
chr14_+_100259666 | 3.44 |
ENST00000262233.6 ENST00000334192.4 |
EML1 |
echinoderm microtubule associated protein like 1 |
chr10_-_62761188 | 3.44 |
ENST00000357917.4 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr6_+_146864829 | 3.43 |
ENST00000367495.3 |
RAB32 |
RAB32, member RAS oncogene family |
chr3_+_110790590 | 3.43 |
ENST00000485303.1 |
PVRL3 |
poliovirus receptor-related 3 |
chr12_-_47473557 | 3.43 |
ENST00000321382.3 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr4_-_157892498 | 3.41 |
ENST00000502773.1 |
PDGFC |
platelet derived growth factor C |
chr14_+_105781048 | 3.39 |
ENST00000458164.2 ENST00000447393.1 |
PACS2 |
phosphofurin acidic cluster sorting protein 2 |
chr11_+_129939811 | 3.39 |
ENST00000345598.5 ENST00000338167.5 |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
chr15_-_83953466 | 3.38 |
ENST00000345382.2 |
BNC1 |
basonuclin 1 |
chr9_+_128509663 | 3.37 |
ENST00000373489.5 ENST00000373483.2 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
chr9_+_131314859 | 3.36 |
ENST00000358161.5 ENST00000372731.4 ENST00000372739.3 |
SPTAN1 |
spectrin, alpha, non-erythrocytic 1 |
chr2_-_242447962 | 3.35 |
ENST00000405883.3 |
STK25 |
serine/threonine kinase 25 |
chr9_+_133320301 | 3.34 |
ENST00000352480.5 |
ASS1 |
argininosuccinate synthase 1 |
chr13_-_45150392 | 3.33 |
ENST00000501704.2 |
TSC22D1 |
TSC22 domain family, member 1 |
chr21_+_46494466 | 3.33 |
ENST00000539173.1 ENST00000389863.4 ENST00000348831.4 ENST00000437626.1 |
ADARB1 |
adenosine deaminase, RNA-specific, B1 |
chr4_+_169753156 | 3.33 |
ENST00000393726.3 ENST00000507735.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr12_-_47473425 | 3.33 |
ENST00000550413.1 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr14_-_89883412 | 3.31 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr11_+_129939779 | 3.27 |
ENST00000533195.1 ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
chr19_-_19051993 | 3.25 |
ENST00000594794.1 ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chrX_+_9983602 | 3.25 |
ENST00000380861.4 |
WWC3 |
WWC family member 3 |
chr9_-_13279589 | 3.24 |
ENST00000319217.7 |
MPDZ |
multiple PDZ domain protein |
chr9_-_139940608 | 3.23 |
ENST00000371601.4 |
NPDC1 |
neural proliferation, differentiation and control, 1 |
chr3_-_124606074 | 3.22 |
ENST00000296181.4 |
ITGB5 |
integrin, beta 5 |
chr11_+_832944 | 3.20 |
ENST00000322008.4 ENST00000397421.1 ENST00000529810.1 ENST00000526693.1 ENST00000525333.1 ENST00000524748.1 ENST00000527341.1 |
CD151 |
CD151 molecule (Raph blood group) |
chr12_-_15942309 | 3.19 |
ENST00000544064.1 ENST00000543523.1 ENST00000536793.1 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr4_-_52904425 | 3.17 |
ENST00000535450.1 |
SGCB |
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
chr9_-_35691017 | 3.16 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr19_+_33685490 | 3.15 |
ENST00000253193.7 |
LRP3 |
low density lipoprotein receptor-related protein 3 |
chr6_-_128841503 | 3.14 |
ENST00000368215.3 ENST00000532331.1 ENST00000368213.5 ENST00000368207.3 ENST00000525459.1 ENST00000368210.3 ENST00000368226.4 ENST00000368227.3 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
chrX_-_154688276 | 3.13 |
ENST00000369445.2 |
F8A3 |
coagulation factor VIII-associated 3 |
chr11_-_2160180 | 3.12 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr3_-_124774802 | 3.11 |
ENST00000311127.4 |
HEG1 |
heart development protein with EGF-like domains 1 |
chr5_+_34656569 | 3.10 |
ENST00000428746.2 |
RAI14 |
retinoic acid induced 14 |
chr15_+_63334831 | 3.08 |
ENST00000288398.6 ENST00000358278.3 ENST00000560445.1 ENST00000403994.3 ENST00000357980.4 ENST00000559556.1 ENST00000559397.1 ENST00000267996.7 ENST00000560970.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr4_-_187644930 | 3.04 |
ENST00000441802.2 |
FAT1 |
FAT atypical cadherin 1 |
chr11_+_832804 | 3.04 |
ENST00000397420.3 ENST00000525718.1 |
CD151 |
CD151 molecule (Raph blood group) |
chrX_+_154611749 | 3.01 |
ENST00000369505.3 |
F8A2 |
coagulation factor VIII-associated 2 |
chr5_+_52776449 | 3.00 |
ENST00000396947.3 |
FST |
follistatin |
chr2_+_20646824 | 3.00 |
ENST00000272233.4 |
RHOB |
ras homolog family member B |
chrX_+_154114635 | 2.97 |
ENST00000369446.2 |
F8A1 |
coagulation factor VIII-associated 1 |
chr7_+_116165754 | 2.97 |
ENST00000405348.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr22_-_50746001 | 2.96 |
ENST00000359337.4 |
PLXNB2 |
plexin B2 |
chr11_+_849816 | 2.96 |
ENST00000527644.1 |
TSPAN4 |
tetraspanin 4 |
chr19_+_3094398 | 2.96 |
ENST00000078429.4 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
chr21_+_35014783 | 2.96 |
ENST00000381291.4 ENST00000381285.4 ENST00000399367.3 ENST00000399352.1 ENST00000399355.2 ENST00000399349.1 |
ITSN1 |
intersectin 1 (SH3 domain protein) |
chr15_-_30114231 | 2.95 |
ENST00000356107.6 ENST00000545208.2 |
TJP1 |
tight junction protein 1 |
chr3_-_129612394 | 2.94 |
ENST00000505616.1 ENST00000426664.2 |
TMCC1 |
transmembrane and coiled-coil domain family 1 |
chr2_+_173292390 | 2.94 |
ENST00000442250.1 ENST00000458358.1 ENST00000409080.1 |
ITGA6 |
integrin, alpha 6 |
chr22_-_50746027 | 2.94 |
ENST00000425954.1 ENST00000449103.1 |
PLXNB2 |
plexin B2 |
chr8_+_26371763 | 2.92 |
ENST00000521913.1 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr1_-_68299130 | 2.91 |
ENST00000370982.3 |
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
chr2_+_148602058 | 2.91 |
ENST00000241416.7 ENST00000535787.1 ENST00000404590.1 |
ACVR2A |
activin A receptor, type IIA |
chr4_+_38869410 | 2.90 |
ENST00000358869.2 |
FAM114A1 |
family with sequence similarity 114, member A1 |
chr14_-_65439132 | 2.89 |
ENST00000533601.2 |
RAB15 |
RAB15, member RAS oncogene family |
chr10_+_89419370 | 2.88 |
ENST00000361175.4 ENST00000456849.1 |
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr14_-_30396948 | 2.88 |
ENST00000331968.5 |
PRKD1 |
protein kinase D1 |
chr9_+_128509624 | 2.88 |
ENST00000342287.5 ENST00000373487.4 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
chr2_-_242447983 | 2.88 |
ENST00000426941.1 ENST00000405585.1 ENST00000420551.1 ENST00000535007.1 ENST00000429279.1 ENST00000442307.1 ENST00000403346.3 ENST00000316586.4 |
STK25 |
serine/threonine kinase 25 |
chr20_+_45338126 | 2.87 |
ENST00000359271.2 |
SLC2A10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
chr9_+_137533615 | 2.86 |
ENST00000371817.3 |
COL5A1 |
collagen, type V, alpha 1 |
chr12_-_15942503 | 2.86 |
ENST00000281172.5 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chrX_+_102631844 | 2.85 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr5_-_127873659 | 2.84 |
ENST00000262464.4 |
FBN2 |
fibrillin 2 |
chr11_+_69455855 | 2.83 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr6_+_151561506 | 2.83 |
ENST00000253332.1 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr2_+_102314161 | 2.81 |
ENST00000425019.1 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chr11_-_65640325 | 2.81 |
ENST00000307998.6 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
chr8_+_30241995 | 2.80 |
ENST00000397323.4 ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS |
RNA binding protein with multiple splicing |
chr11_-_86666427 | 2.80 |
ENST00000531380.1 |
FZD4 |
frizzled family receptor 4 |
chr20_-_17662878 | 2.79 |
ENST00000377813.1 ENST00000377807.2 ENST00000360807.4 ENST00000398782.2 |
RRBP1 |
ribosome binding protein 1 |
chr11_+_12399071 | 2.78 |
ENST00000539723.1 ENST00000550549.1 |
PARVA |
parvin, alpha |
chr22_-_36424458 | 2.78 |
ENST00000438146.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr6_-_52441713 | 2.76 |
ENST00000182527.3 |
TRAM2 |
translocation associated membrane protein 2 |
chr6_+_142623063 | 2.75 |
ENST00000296932.8 ENST00000367609.3 |
GPR126 |
G protein-coupled receptor 126 |
chr5_+_52776228 | 2.75 |
ENST00000256759.3 |
FST |
follistatin |
chr8_+_42995548 | 2.75 |
ENST00000458501.2 ENST00000379644.4 |
HGSNAT |
heparan-alpha-glucosaminide N-acetyltransferase |
chr5_+_52285144 | 2.75 |
ENST00000296585.5 |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr17_-_56032684 | 2.74 |
ENST00000577830.1 |
CUEDC1 |
CUE domain containing 1 |
chr10_+_124134201 | 2.74 |
ENST00000368990.3 ENST00000368988.1 ENST00000368989.2 ENST00000463663.2 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
chr2_-_110371664 | 2.74 |
ENST00000545389.1 ENST00000423520.1 |
SEPT10 |
septin 10 |
chr2_-_158732340 | 2.71 |
ENST00000539637.1 ENST00000413751.1 ENST00000434821.1 ENST00000424669.1 |
ACVR1 |
activin A receptor, type I |
chr1_+_9352939 | 2.71 |
ENST00000328089.6 |
SPSB1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
chr4_-_102268484 | 2.69 |
ENST00000394853.4 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 17.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
2.4 | 7.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
2.3 | 13.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.2 | 2.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.7 | 5.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.6 | 4.8 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.5 | 7.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.4 | 7.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.4 | 5.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.3 | 5.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.2 | 12.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 5.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.1 | 4.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.1 | 17.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 3.3 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.1 | 3.2 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.1 | 8.5 | GO:0045159 | myosin II binding(GO:0045159) |
1.1 | 4.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.1 | 3.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.0 | 7.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 36.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.0 | 9.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.9 | 0.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.9 | 15.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.9 | 5.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.9 | 5.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.9 | 4.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.9 | 4.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.9 | 10.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.9 | 3.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.9 | 3.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.9 | 6.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.9 | 10.3 | GO:0048185 | activin binding(GO:0048185) |
0.8 | 5.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.8 | 2.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.8 | 5.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 3.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 5.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.8 | 3.2 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 3.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 2.4 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.8 | 4.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.8 | 3.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 34.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 3.0 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.7 | 2.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 12.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 2.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.7 | 2.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.7 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.7 | 4.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.7 | 2.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.7 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 3.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 15.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.6 | 3.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 5.1 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 2.6 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.6 | 7.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 3.8 | GO:1903135 | cupric ion binding(GO:1903135) |
0.6 | 2.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.6 | 3.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 9.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.6 | 2.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.6 | 14.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 2.3 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.6 | 2.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 1.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.6 | 2.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 1.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.6 | 1.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.6 | 3.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 1.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 2.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 12.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.5 | 1.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 12.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.5 | 2.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.5 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 4.0 | GO:0005497 | androgen binding(GO:0005497) |
0.5 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.5 | 7.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 3.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.5 | 1.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.5 | 11.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 2.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.5 | 4.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 7.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.5 | 4.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 0.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.5 | 40.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 1.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 9.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.8 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.5 | 1.8 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.5 | 3.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 2.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.4 | 4.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.4 | 1.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.4 | 2.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 5.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 2.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.7 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 13.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.4 | 5.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 5.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.4 | 3.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 0.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 9.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 3.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 3.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 10.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 2.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.3 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.4 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 4.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.3 | 5.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 5.4 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 23.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 8.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 11.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 42.4 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 6.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 1.6 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 4.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.3 | 2.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 5.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.3 | 4.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 1.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 0.6 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 1.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 7.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 6.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 0.9 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.3 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 7.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 2.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.9 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.3 | 30.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.3 | 1.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 10.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.8 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.3 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 1.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 2.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 5.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 5.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 21.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 2.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 2.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.2 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.2 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 3.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 7.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 3.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 5.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 2.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 3.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 3.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 3.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.9 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.2 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 2.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 14.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 5.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 5.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 17.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 2.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 6.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 3.1 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.0 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 1.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 2.5 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 8.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 4.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 2.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 2.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 4.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 20.7 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 8.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 3.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 4.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 6.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 2.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.7 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 19.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 3.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 3.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 3.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 1.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.6 | GO:0047708 | biotinidase activity(GO:0047708) |
0.2 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 1.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.6 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 17.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0030305 | heparanase activity(GO:0030305) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 1.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 9.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 2.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.8 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 1.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 11.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 3.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.2 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.2 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 19.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.7 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 5.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 5.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 3.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.2 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.1 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 2.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 19.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 16.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0015645 | long-chain fatty acid-CoA ligase activity(GO:0004467) fatty acid ligase activity(GO:0015645) |
0.1 | 1.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 9.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 2.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 16.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.0 | 0.0 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.0 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0046979 | TAP2 binding(GO:0046979) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.7 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.7 | 8.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
2.6 | 30.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.4 | 7.2 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
2.2 | 6.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
2.1 | 10.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
2.1 | 10.4 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
2.0 | 6.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 17.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.9 | 7.5 | GO:0021564 | vagus nerve development(GO:0021564) |
1.9 | 5.6 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
1.9 | 5.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.8 | 11.1 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.8 | 14.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.8 | 5.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.7 | 8.5 | GO:0030047 | actin modification(GO:0030047) |
1.6 | 8.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.6 | 4.8 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
1.6 | 4.7 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
1.5 | 5.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.4 | 4.3 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.4 | 5.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
1.4 | 5.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.4 | 1.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.4 | 5.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.3 | 1.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.3 | 5.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.3 | 9.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.3 | 6.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
1.3 | 5.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.3 | 5.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
1.3 | 5.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.3 | 8.9 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.3 | 10.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.2 | 7.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.2 | 9.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.2 | 7.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.2 | 4.8 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
1.2 | 13.2 | GO:0009414 | response to water deprivation(GO:0009414) |
1.2 | 4.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.2 | 13.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.2 | 4.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.1 | 4.6 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
1.1 | 10.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 2.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.1 | 4.4 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
1.1 | 14.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.1 | 4.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
1.1 | 7.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.1 | 4.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.0 | 1.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.0 | 5.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.0 | 4.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.0 | 5.9 | GO:0030421 | defecation(GO:0030421) |
1.0 | 3.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.0 | 4.9 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.0 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
1.0 | 5.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.9 | 2.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.9 | 3.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.9 | 1.9 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.9 | 9.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.9 | 3.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.9 | 9.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 10.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.9 | 1.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.9 | 5.4 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.9 | 4.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.9 | 2.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.9 | 25.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 4.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.8 | 6.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.8 | 9.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.8 | 3.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.8 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.8 | 3.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 0.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.8 | 0.8 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.8 | 3.2 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.8 | 7.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.8 | 3.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 3.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.8 | 0.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.8 | 6.0 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.8 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 3.8 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.8 | 3.8 | GO:0051414 | response to cortisol(GO:0051414) |
0.8 | 3.0 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.7 | 0.7 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.7 | 5.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.7 | 1.5 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.7 | 0.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.7 | 2.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 2.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.7 | 3.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 5.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.7 | 2.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.7 | 2.1 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.7 | 5.6 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.7 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 0.7 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.7 | 2.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.7 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 5.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 2.7 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.7 | 2.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.7 | 10.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 6.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.7 | 3.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.7 | 14.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 6.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.7 | 2.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 10.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 2.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.6 | 3.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 3.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 6.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.6 | 4.5 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 1.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.6 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.6 | 1.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.6 | 6.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.6 | 2.4 | GO:0009956 | radial pattern formation(GO:0009956) |
0.6 | 1.8 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.6 | 1.8 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.6 | 1.8 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 1.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.6 | 13.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 4.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 2.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 1.2 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 1.2 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.6 | 2.4 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.6 | 1.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 1.8 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 1.2 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.6 | 1.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.6 | 2.9 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 6.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 3.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.6 | 2.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 2.3 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.6 | 4.0 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.6 | 2.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.6 | 1.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.6 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.6 | 10.1 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.6 | 2.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 0.6 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.6 | 1.7 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.6 | 1.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.5 | 2.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 3.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 3.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.1 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.5 | 1.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 2.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.5 | 4.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 2.1 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.5 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 12.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 1.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 2.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 1.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.5 | 1.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 10.9 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 7.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 3.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 2.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.5 | 1.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 2.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.5 | 3.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 3.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 0.5 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) negative regulation of gastrulation(GO:2000542) |
0.5 | 2.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 1.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 2.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 1.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.5 | 19.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 6.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.5 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 6.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 3.3 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.5 | 1.4 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.5 | 1.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 1.4 | GO:0009183 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.5 | 1.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.5 | 1.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 2.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.9 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.5 | 1.9 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.5 | 3.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 0.9 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.5 | 9.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.5 | 1.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 1.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 1.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.5 | 1.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 4.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 0.5 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.4 | 0.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 9.4 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 4.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 4.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.4 | 3.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 1.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.4 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 1.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 1.3 | GO:1902617 | response to fluoride(GO:1902617) |
0.4 | 1.7 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 0.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.4 | 1.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 2.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 2.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 0.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 1.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.4 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 2.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 0.4 | GO:0072007 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) |
0.4 | 2.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 7.9 | GO:0071711 | basement membrane organization(GO:0071711) |
0.4 | 1.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.4 | 0.8 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.4 | 2.0 | GO:1903412 | response to bile acid(GO:1903412) |
0.4 | 1.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.4 | 0.8 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 0.4 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 1.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.4 | 7.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 1.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.4 | 3.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.4 | 1.6 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 3.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.2 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.4 | 1.5 | GO:0071306 | cellular response to vitamin E(GO:0071306) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.4 | 2.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.5 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 | 13.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 0.4 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 3.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 1.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 1.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 2.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 1.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 3.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 4.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 3.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.7 | GO:0000050 | urea cycle(GO:0000050) |
0.4 | 0.7 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.4 | 1.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.4 | 2.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.4 | 0.7 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.4 | 1.8 | GO:0001705 | ectoderm formation(GO:0001705) |
0.4 | 0.4 | GO:1904304 | melanocyte migration(GO:0097324) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.4 | 2.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 1.0 | GO:2000768 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.3 | 1.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 2.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 1.0 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.3 | 8.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.3 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 2.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 6.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 0.3 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.3 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.7 | GO:0010269 | response to selenium ion(GO:0010269) |
0.3 | 1.3 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 2.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 3.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 16.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 2.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 1.0 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.3 | 3.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.3 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 2.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 1.0 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.3 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 0.6 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.3 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 1.0 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.3 | 2.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.3 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.3 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 1.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 3.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 3.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.9 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.3 | 2.2 | GO:0046618 | drug export(GO:0046618) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 5.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 1.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.3 | 0.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.9 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.3 | 1.5 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.3 | 3.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 3.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 1.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.9 | GO:0014900 | smooth muscle hyperplasia(GO:0014806) muscle hyperplasia(GO:0014900) |
0.3 | 3.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 0.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 2.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 5.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.3 | 0.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 2.8 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 0.8 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) |
0.3 | 4.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 3.1 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 1.1 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 3.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.3 | 1.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.3 | 0.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.3 | 0.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 4.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.1 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.4 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.3 | 1.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.8 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.3 | 1.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.3 | 6.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 0.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 3.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 1.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 2.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 0.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.3 | 0.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 1.0 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.3 | 0.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 2.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.3 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.3 | 2.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.5 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 1.8 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.3 | 0.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 7.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.3 | 5.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.3 | 0.5 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.3 | 1.8 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.3 | 3.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 0.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 1.5 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 2.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 2.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 2.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 6.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.2 | 15.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.7 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 1.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 1.5 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 2.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.7 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.5 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
0.2 | 1.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 5.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 5.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.2 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.4 | GO:0043217 | myelin maintenance(GO:0043217) |
0.2 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 2.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.2 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
0.2 | 0.7 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 1.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 0.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 0.9 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 0.7 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.2 | 0.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.7 | GO:0071709 | membrane assembly(GO:0071709) |
0.2 | 0.4 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.2 | 3.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.2 | 10.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 3.4 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 1.0 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
0.2 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.4 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.4 | GO:0003285 | septum secundum development(GO:0003285) |
0.2 | 1.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 2.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 3.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 2.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.2 | GO:0034329 | cell junction assembly(GO:0034329) |
0.2 | 12.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 3.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 2.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 1.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 2.2 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.8 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.2 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 2.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.2 | 0.2 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.2 | 0.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 1.9 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.6 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.2 | 0.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 4.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 0.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 10.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 1.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 4.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 2.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 1.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.4 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) operant conditioning(GO:0035106) acetylcholine secretion(GO:0061526) |
0.2 | 1.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 1.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 1.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 0.3 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 1.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 1.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 3.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.2 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 2.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.2 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
0.2 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 0.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.2 | 0.5 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.2 | 2.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 1.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.2 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.2 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 2.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 2.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.6 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.2 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.5 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.2 | 1.1 | GO:0042426 | choline catabolic process(GO:0042426) |
0.2 | 0.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.2 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 1.0 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.4 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 1.5 | GO:0007567 | parturition(GO:0007567) |
0.1 | 2.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.6 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 1.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.1 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 1.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 2.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 1.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:2000397 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 2.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 4.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.1 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 3.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 5.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 2.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 3.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 1.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.4 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 3.2 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.3 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0060295 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.1 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
0.1 | 0.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 1.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.7 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.6 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.1 | 0.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 1.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.7 | GO:0048793 | pronephros development(GO:0048793) |
0.1 | 0.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.4 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.1 | 1.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.5 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.1 | 2.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 2.3 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 4.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.1 | GO:0071287 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) cellular response to manganese ion(GO:0071287) |
0.1 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 1.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.7 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 1.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.2 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.1 | 0.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 2.9 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.7 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.1 | 1.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 1.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 2.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 2.5 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.5 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.8 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 2.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) |
0.1 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 2.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.2 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.1 | 2.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.9 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 3.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 2.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.1 | GO:0032640 | tumor necrosis factor production(GO:0032640) |
0.1 | 0.7 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.8 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.1 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 4.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.5 | GO:1902932 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) positive regulation of alcohol biosynthetic process(GO:1902932) |
0.1 | 11.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.3 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.2 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 0.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) |
0.1 | 1.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.1 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 5.3 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.1 | 0.2 | GO:0045188 | optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.1 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 1.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0001736 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 2.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.5 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.1 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.3 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.2 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 1.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 4.8 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.5 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.4 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.1 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 3.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 2.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.6 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.1 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 1.8 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.0 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 3.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.6 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 1.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.0 | GO:0035524 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.6 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 7.1 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.8 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.2 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.0 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.0 | 0.1 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 3.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:1902913 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 1.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.0 | 1.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.7 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.0 | 0.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.0 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 2.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 1.7 | GO:0016050 | vesicle organization(GO:0016050) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.1 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.3 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.0 | 0.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.0 | 0.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.2 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.0 | 0.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.2 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.1 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.3 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.0 | 0.0 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.0 | 1.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.0 | GO:2000157 | negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.0 | 0.0 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.0 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.0 | 0.1 | GO:0007281 | germ cell development(GO:0007281) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.5 | 7.6 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
2.0 | 6.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.5 | 5.9 | GO:0045160 | myosin I complex(GO:0045160) |
1.5 | 7.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.3 | 17.0 | GO:0097470 | ribbon synapse(GO:0097470) |
1.3 | 24.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.2 | 3.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.2 | 5.8 | GO:0032449 | CBM complex(GO:0032449) |
1.2 | 6.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 3.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.1 | 16.2 | GO:0005916 | fascia adherens(GO:0005916) |
1.0 | 7.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.0 | 4.0 | GO:0031673 | H zone(GO:0031673) |
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 0.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.8 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.8 | 5.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.8 | 15.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.8 | 2.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.8 | 0.8 | GO:0000806 | Y chromosome(GO:0000806) |
0.8 | 23.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 6.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 3.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 8.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 2.9 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.7 | 5.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 7.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 2.8 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.7 | 0.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.7 | 2.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 6.3 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 7.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 5.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.6 | 0.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.6 | 6.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 2.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.6 | 0.6 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.6 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 1.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 4.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 6.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 7.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 10.5 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 2.2 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.5 | 6.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 2.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 18.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 2.6 | GO:0031905 | early endosome lumen(GO:0031905) |
0.5 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 4.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 1.9 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 2.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 1.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.5 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 12.8 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 46.0 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 15.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 4.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 0.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.2 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.4 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 3.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 5.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 9.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 7.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 4.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 3.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 6.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 2.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 10.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 2.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 2.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 4.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 2.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.3 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 3.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 7.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 3.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 6.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 4.3 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 9.0 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 22.6 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.7 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 84.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 19.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 1.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 1.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.3 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 2.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 26.6 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.3 | 0.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 1.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 5.6 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.2 | 1.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 1.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.2 | 2.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 17.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 8.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 3.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 7.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 25.0 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.2 | 0.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 2.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.4 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 14.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 99.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 15.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 2.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 4.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 3.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 3.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 1.4 | GO:0033643 | host cell part(GO:0033643) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 3.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 3.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 18.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.2 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 1.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 10.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 12.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 5.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 4.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 4.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.2 | 5.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 10.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.5 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 5.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 1.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 6.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 13.5 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 11.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 5.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 3.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 0.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 8.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 16.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 6.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.0 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 2.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 6.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.4 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 23.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 3.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 1.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 2.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 3.7 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0098857 | membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 2.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 1.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.8 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 1.4 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 9.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 2.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 3.1 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 2.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 4.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 16.0 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0044217 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 3.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 2.7 | GO:0009986 | cell surface(GO:0009986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 18.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 2.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 30.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.7 | 37.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 23.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 11.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 14.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 13.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 28.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 6.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 12.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 22.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 16.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 10.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 7.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 2.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 7.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 7.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 25.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 16.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 8.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 13.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 10.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 20.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 4.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 21.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 17.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 45.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 36.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 17.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 51.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 7.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 4.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 3.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 9.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 4.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 4.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 4.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 5.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 2.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 5.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.0 | 49.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 24.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 5.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 20.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 14.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 13.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 7.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 11.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.7 | 2.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 14.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.6 | 10.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.6 | 5.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 37.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 10.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 12.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 5.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 4.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 13.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 8.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 4.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 13.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 8.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 2.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 12.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 5.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 6.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 7.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 6.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 13.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 6.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 21.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 10.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 5.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 8.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 6.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 10.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 6.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 24.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 1.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.2 | 6.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 4.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 4.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 10.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 4.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 3.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 8.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 12.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 7.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 6.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 5.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 8.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 3.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 3.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 1.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 9.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 5.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 3.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 5.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 1.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 3.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 1.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 2.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |